Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets

Transfusion

Volumn 55, Issue 2, 2015, Pages 296-300

  Savage, William J ^a   Tobian, Aaron A R ^b   Savage, Jessica H ^a   Hamilton, Robert G ^b   Borge, P Dayand ^c   Kaufman, Richard M ^a   Ness, Paul M ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ADOLESCENT; ADULT; AGED; ALLERGIC TRANSFUSION REACTION; ALLERGY; ANAPHYLAXIS; ANTIBODY SCREENING; APHERESIS; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD TRANSFUSION REACTION; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFUSION; INFUSION RATE; INFUSION VOLUME; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; THROMBOCYTE TRANSFUSION; UNIVERSITY HOSPITAL; AGE; CLINICAL TRIAL; COMPARATIVE STUDY; FACTUAL DATABASE; HYPERSENSITIVITY; MIDDLE AGED; PRESCHOOL CHILD; THROMBOCYTOPHERESIS; VERY ELDERLY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; PLATELET TRANSFUSION; PLATELETPHERESIS; RISK FACTORS;

EID: 84922983599     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12852     Document Type: Article

References (29)

1. Heddle NM, Blajchman MA, Meyer RM, et al. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 2002; 42: 556-566.
2. Savage WJ, Tobian AA, Fuller AK, et al. Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes. Transfusion 2011; 51: 1716-1722.
3. Tobian AA, Savage WJ, Tisch DJ, et al. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion 2011; 51: 1676-1683.
4. Tobian AA, Fuller AK, Uglik K, et al. The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment. Transfusion 2014; 54: 1523-1529; quiz 1522.
5. Vyas GN, Perkins HA, Fudenberg HH,. Anaphylactoid transfusion reactions associated with anti-IgA. Lancet 1968; 2 (7563): 312-315.
6. Shimada E, Tadokoro K, Watanabe Y, et al. Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies. Transfusion 2002; 42: 766-773.
7. Lambin P, Le Pennec PY, Hauptmann G, et al. Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificity. Vox Sang 1984; 47: 242-249.
8. Morishita K, Wakamoto S, Miyazaki T, et al. Life-threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti-CD36 (Nak) isoantibody. Transfusion 2005; 45: 803-806.
9. Arnold DM, Blajchman MA, Ditomasso J, et al. Passive transfer of peanut hypersensitivity by fresh frozen plasma. Arch Intern Med 2007; 167: 853-854.
10. Abe T, Matsumoto C, Shimada E, et al. Immunoglobulin E oligomers identified in blood components activate mast cells: relevance to anaphylactic transfusion reaction. Transfusion 2011; 51: 2327-2336.
11. Poisson JL, Riedo FX, Aubuchon JP,. Acquired peanut hypersensitivity after transfusion. Transfusion 2014; 54: 256-257.
12. Branch DR, Gifford H,. Allergic reaction to transfused cephalothin antibody. JAMA 1979; 241: 495-496.
13. Azuma H, Yamaguchi M, Takahashi D, et al. Elevated Ca(2+) influx-inducing activity toward mast cells in pretransfusion sera from patients who developed transfusion-related adverse reactions. Transfusion 2009; 49: 1754-1761.
14. Wilhelm D, Kluter H, Klouche M, et al. Impact of allergy screening for blood donors: relationship to nonhemolytic transfusion reactions. Vox Sang 1995; 69: 217-221.
15. Savage WJ, Tobian AA, Savage JH, et al. Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets. Transfusion 2011; 51: 2337-2342.
16. Savage WJ, Hamilton RG, Tobian AA, et al. Defining risk factors and presentations of allergic reactions to platelet transfusion. J Allergy Clin Immunol 2014; 133: 1772-5.e9.
17. Savage WJ, Tobian AA, Savage JH, et al. Scratching the surface of allergic transfusion reactions. Transfusion 2013; 53: 1361-1371.
18. Tobian AA, King KE, Ness PM,. Transfusion premedications: a growing practice not based on evidence. Transfusion 2007; 47: 1089-1096.
19. Henrichs KF, Howk N, Masel DS, et al. Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence. Transfusion 2012; 52: 635-640.
20. Sarkodee-Adoo CB, Kendall JM, Sridhara R, et al. The relationship between the duration of platelet storage and the development of transfusion reactions. Transfusion 1998; 38: 229-235.
21. Xiao W, Tormey CA, Capetillo A, et al. Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components. Vox Sang 2013; 105: 334-340.
22. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391-397.
23. Stiehm ER,. Adverse effects of human immunoglobulin therapy. Transfus Med Rev 2013; 27: 171-178.
24. Hong DI, Dioun AF,. Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children. J Allergy Clin Immunol Pract 2014; 2: 13-19; quiz 20.
25. Simons FE, Simons KJ,. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol 2011; 128: 1139-1150 e1134.
26. Marti-Carvajal AJ, Sola I, Gonzalez LE, et al. Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions. Cochrane Database Syst Rev 2010;(6): CD007539.
27. Kennedy LD, Case LD, Hurd DD, et al. A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions. Transfusion 2008; 48: 2285-2291.
28. Wang SE, Lara PN Jr, Lee-Ow A, et al. Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial. Am J Hematol 2002; 70: 191-194.
29. Sanders RP, Maddirala SD, Geiger TL, et al. Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children. Br J Haematol 2005; 130: 781-787.